Robert Balk to Biomarkers
This is a "connection" page, showing publications Robert Balk has written about Biomarkers.
Connection Strength
0.887
-
The Role of Biomarkers in the Diagnosis and Management of Pneumonia. Clin Chest Med. 2018 12; 39(4):691-701.
Score: 0.494
-
Real-world use of procalcitonin and other biomarkers among sepsis hospitalizations in the United States: A retrospective, observational study. PLoS One. 2018; 13(10):e0205924.
Score: 0.122
-
Procalcitonin as a Marker of Etiology in Adults Hospitalized With Community-Acquired Pneumonia. Clin Infect Dis. 2017 Jul 15; 65(2):183-190.
Score: 0.112
-
Evaluating the adequacy of fluid resuscitation in patients with septic shock: controversies and future directions. Hosp Pract (1995). 2012 Apr; 40(2):147-57.
Score: 0.078
-
COVID-19 Severity Is Associated with Differential Antibody Fc-Mediated Innate Immune Functions. mBio. 2021 04 20; 12(2).
Score: 0.036
-
Procalcitonin as an Early Marker of the Need for Invasive Respiratory or Vasopressor Support in Adults With Community-Acquired Pneumonia. Chest. 2016 Oct; 150(4):819-828.
Score: 0.026
-
Multinational, observational study of procalcitonin in ICU patients with pneumonia requiring mechanical ventilation: a multicenter observational study. Crit Care. 2011; 15(2):R88.
Score: 0.018